₹38.33
▲ +2.57 +7.19%
30 Jul 2026
NSE Listed · Trading
Fischer Medical Venture Limited (FISCHER)
Volume: 30,82,047Avg Vol 1W: 23,96,635Avg Vol 1M: 26,52,79652W Range:₹31.05₹124.7
Key Ratios
Checked 2h agoMarket Cap₹2,513 Cr
Current Price₹38.33
Previous Close₹35.76
High / Low (52w)₹124.7 / ₹31.05
Volume30,82,047
Avg Vol (1W)23,96,635
Avg Vol (1M)26,52,796
Stock P/E—
Book Value₹5.88
Dividend Yield0.14%
ROE8.06%
ROA4.63%
Revenue (TTM)—
Revenue Growth427.61%
Profit Margin10.06%
Total Debt₹26,25,000 Cr
Shares Outstanding65 Cr
Face Value₹1
EPS (TTM)₹-0.11
P/B6.53
Debt / Equity0.28
50 DMA₹36.86
200 DMA₹45.7
Day change+7.19%
Price Chart
₹38.33▼ 60.23% · 1Y
2025-07-302026-07-30
20-day avg volume: 25.6L shares
Pros
- Company is almost debt-free.
- Revenue grew 211% YoY.
Cons
- Company is loss-making at the latest annual result.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹10 Cr | ₹40 Cr | ₹12 Cr | ₹49 Cr | ₹23 Cr | ₹86 Cr | ₹101 Cr | ₹98 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹2 Cr | ₹11 Cr | ₹18 Cr | ₹22 Cr | ₹1 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹5 Cr | ₹14 Cr | ₹19 Cr | ₹-7 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹0 Cr | ₹0 Cr | ₹112 Cr | ₹5 Cr | ₹5 Cr | ₹7 Cr | ₹1 Cr | ₹4 Cr |
| EBITDA | ₹0 Cr | ₹1 Cr | ₹3 Cr | ₹-1 Cr | ₹1 Cr | ₹3 Cr | ₹-1 Cr | ₹-9 Cr |
| Net Profit | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹-1 Cr | ₹-1 Cr | ₹1 Cr | ₹-2 Cr | ₹-9 Cr |
| EPS | — | — | 0.08 | — | — | — | — | — |
Balance Sheet
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Total Assets | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹86 Cr | ₹457 Cr |
| Total Liabilities | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹5 Cr | ₹120 Cr |
| Equity | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹81 Cr | ₹338 Cr |
| Total Debt | ₹0 Cr | ₹0 Cr | ₹0 Cr | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-7 Cr | ₹-86 Cr |
| Investing | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-31 Cr | ₹-125 Cr |
| Financing | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹37 Cr | ₹315 Cr |
| Free Cash Flow | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-7 Cr | ₹-86 Cr |
Shareholding
Promoter 62.15% Institutions 6.83% Public 31.02%
Efficiency & Working Capital
ROCE0.5%
Interest Coverage5.5
Dividend Payout—
Debtor Days251 d
Inventory Days30 d
Payable Days68 d
Cash Conversion Cycle213 d
Working Capital Days281 d
Shareholding Details
As of 2026-06-30
Promoter62.1%
FII5.5%
DII1.3%
Institutions6.8%
Public31%
Promoter Pledge7.4%
No. of Shareholders23,950
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Dec 2024 | Feb 2025 | Mar 2025 | Apr 2025 | Apr 2025 | Jun 2025 | Jul 2025 | Jul 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 74.9% | 62.8% | 62.8% | 61.8% | 61.8% | 61.8% | 61.8% | 61.8% | 61.8% | 61.8% | 62.1% | 62.1% |
| FIIs | 5.1% | 5.1% | 5.2% | 5.4% | 5.4% | 5.6% | 5.6% | 5.6% | 5.6% | 4.9% | 5% | 5.5% |
| DIIs | 1.7% | 1.4% | 1.4% | 1.4% | 1.4% | 1.4% | 1.4% | 0% | 1.4% | 1.4% | 1.4% | 1.3% |
| Public | 18.3% | 30.7% | 30.5% | 31.4% | 31.4% | 31.2% | 31.2% | 32.6% | 31.2% | 32% | 31.5% | 31% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 7.4% | 7.4% |
| No. of Shareholders | 9,688 | 9,865 | 10,180 | 10,182 | 10,182 | 10,058 | 10,050 | 10,050 | 13,054 | 22,920 | 23,269 | 23,950 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Fmv Holdings Pte Ltd | Shareholding of Promoter and Promoter Group | 50.7% | 33.18 Cr |
| Shankar Varadharajan | Shareholding of Promoter and Promoter Group | 11.5% | 7.50 Cr |
| Roopal Hitesh Kawa . | Public Shareholding | 2.7% | 1.78 Cr |
| Vikasa India Eif I Fund | Public Shareholding | 2.5% | 1.67 Cr |
| India Emerging Giants Fund Limited | Public Shareholding | 2.5% | 1.62 Cr |
| Vinay Rajendrakumar Nagda | Public Shareholding | 1.5% | 1.00 Cr |
| Blue Lotus Capital Multi Bagger Fund Ii | Public Shareholding | 1.4% | 88,15,820 |
| L7 Hitech Private Limited | Public Shareholding | 1.3% | 81,56,648 |
| Kaushik Hasmukhlal Gandhi . | Public Shareholding | 1.2% | 79,50,000 |
| Natwarlal Keshavjibhai Kawa . | Public Shareholding | 1.2% | 77,38,320 |
| Hitesh Natwarlal Kawa . | Public Shareholding | 1.1% | 71,56,790 |
| Nimesh Sahadeo Singh | Public Shareholding | 1.1% | 69,71,530 |
| Ks Smart Technologies Ltd | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Ravindran Govindan | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Mercatus Capital Pte Ltd | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Time Medical Holdings Company Ltd | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Eight Mercatus Pte. Ltd | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Neuome Peptides Pte Ltd | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Mercatus Medtech Pte Ltd | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Infinite Diagnostics Pte Ltd | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Eight Mighty Ventures Pte Ltd | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Eight Ndx Ventures Pte Ltd | Shareholding of Promoter and Promoter Group | 0% | 0 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Shankar Varadharajan | 3.00 Cr | 40% | 2026-06-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| RAVINDRAN GOVINDAN | ED / MD / Promoter | 2025 |
| Svetlana Rao | E D & Wholetime Director | 2025 |
| Sanjay Jayantilal Jain | Independent Non Exe. Director | 2025 |
| Khairy Jamaluddin Abu Bakkar | Independent Non Exe. Director | 2025 |
| Jacob Thomas | Independent Non Exe. Director | 2025 |
| Roberto M Pagdanganan | Independent Non Exe. Director | 2025 |
| JAYA ANKUR SINGHANIA | Independent Non Exe. Director | 2025 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 80 | 64 | 64 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| dividend | 2025-09-22 | ₹0.005 (0.5%) | Final |
| split | 2025-09-12 | 1:10 | face value change from 10 to 1 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 4 | 0 | 0 | 5 | 17 |
| 2025 | 0 | 4 | 0 | 0 | 0 | 4 |
| 2025 | 0 | 0 | 0 | 0 | 5 | 12 |
Insider / Designated-Person Trades
2 recent disclosure(s)
Shankar VaradharajanAcquisition · 60,00,000
SHANKAR VARADHARAJANPledge · 3,00,00,000
Substantial Acquisitions (SAST)
3 disclosure(s)
Pref. Allotment18/02/2025 · —
Pref. Allotment25/01/2024 · 4,00,76,260
Pref. Allotment25/01/2024 · 40,35,000
Company Information
🌐 www.fischerchemic.in ↗
📍 104 1st Fl Bhhind Poisar Depot, Raghuleela Mall Kandivali (W), Mumbai, Maharashtra, 400067
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Finolex Cables Ltd.Fine Organic Industries Ltd.Finkurve Financial Serv LimitedFino Payments Bank Ltd.Finolex Industries Ltd.Brainbees Solutions Ltd.Five-Star Business Finance Ltd.Flair Writing Industries Ltd.Flexituff Ventures International Ltd.Future Lifestyle Fashions Ltd.Gujarat Fluorochemicals Ltd.FlySBS Aviation LimitedAll “F” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search